Episode 168: Is It Really "Bad Weed"? The Science and Data of CHS with Dr. Codi Peterson
Despite its rising prevalence in emergency departments, medical science is still catching up to Cannabinoid Hyperemesis Syndrome (CHS).
To bridge this gap, clinical pharmacist Dr. Codi Peterson recently led a landmark, IRB-approved study analyzing the symptom profiles and cannabis use patterns of 1,134 individuals.
In our upcoming podcast episode, Dr. Peterson breaks down the paper's key findings, including how delivery methods affect symptom onset, the role of genetic predisposition, and the critical importance of early "prodrome" identification to prevent severe hospitalizations.
This conversation is essential listening for cultivators, clinicians, policy makers, and consumers alike.
Link to the paper:
Cannabinoid Hyperemesis Syndrome-A Survey-Based Approach to Understanding Symptoms and Cannabis Use Patterns
https://pubmed.ncbi.nlm.nih.gov/41783912/
